SEC Form SC 13G filed by Chemomab Therapeutics Ltd.
CUSIP No. 16385C104
|
13G
|
Page 2 of 9 Pages
|
1
|
NAME OF REPORTING PERSONS
Sphera Funds Management Ltd.
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b) ☒
|
|
3
|
SEC USE ONLY
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
--
|
6
|
SHARED VOTING POWER
1,214,575 (*)
|
|
7
|
SOLE DISPOSITIVE POWER
--
|
|
8
|
SHARED DISPOSITIVE POWER
1,214,575 (*)
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,214,575 (*)
|
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.56% (*) (**)
|
|
12
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
CUSIP No. 16385C104
|
13G
|
Page 3 of 9 Pages
|
1
|
NAME OF REPORTING PERSONS
Sphera Global Healthcare GP Ltd.
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b) ☒
|
|
3
|
SEC USE ONLY
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
--
|
6
|
SHARED VOTING POWER
1,214,575 (*)
|
|
7
|
SOLE DISPOSITIVE POWER
--
|
|
8
|
SHARED DISPOSITIVE POWER
1,214,575 (*)
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,214,575 (*)
|
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.56% (*) (**)
|
|
12
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
CUSIP No. 16385C104
|
13G
|
Page 4 of 9 Pages
|
1
|
NAME OF REPORTING PERSONS
Sphera Global Healthcare Management LP
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b) ☒
|
|
3
|
SEC USE ONLY
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
--
|
6
|
SHARED VOTING POWER
1,214,575 (*)
|
|
7
|
SOLE DISPOSITIVE POWER
--
|
|
8
|
SHARED DISPOSITIVE POWER
1,214,575 (*)
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,214,575 (*)
|
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.56% (*) (**)
|
|
12
|
TYPE OF REPORTING PERSON (See instructions)
PN
|
Item 1. (a) |
Name of Issuer:
|
(b) |
Address of Issuer's Principal Executive Offices:
|
Item 2. (a) |
Name of Person Filing:
|
(b) |
Address of Principal Business Office:
|
(c) |
Citizenship:
|
(d) |
Title of Class of Securities:
|
(e) |
CUSIP Number:
|
Item 3. |
Not applicable.
|
Item 4. |
Ownership:
|
(a) |
Amount beneficially owned:
|
• |
1,214,575 ADSs, representing a total of 6.56% of the total ADSs outstanding, are held directly by Sphera Biotech Master Fund, which has delegated its investment management authority to Sphera Global Healthcare Management LP (the "Management
Company").
|
(b) |
Percent of class:
|
(c) |
Number of shares as to which such person has:
|
(i) |
Sole power to vote or to direct the vote:
|
(ii) |
Shared power to vote or to direct the vote:
|
(iii) |
Sole power to dispose or to direct the disposition of:
|
(iv) |
Shared power to dispose or to direct the disposition of:
|
Item 5. |
Ownership of Five Percent or Less of a Class:
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another:
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
|
Item 8. |
Identification and Classification of Members of the Group:
|
Item 9. |
Notice of Dissolution of Group:
|
Item 10. |
Certification:
|
Sphera Funds Management Ltd.
/s/ Oshrat Levi By: Oshrat Levi
Title: CFO Sphera Global Healthcare GP Ltd.
/s/ Oshrat Levi By: Oshrat Levi Title: CFO Sphera Global Healthcare Management LP
/s/ Oshrat Levi By: Oshrat Levi Title: CFO |
Exhibit 1 |